4-Acetoxy-N,N-dimethyltryptamine, commonly referred to as 4-AcO-DMT or psilacetin, is a less explored psychedelic compound belonging to the tryptamine family. It shares structural similarities with psilocybin and psilocin, active components of psilocybin mushrooms. Though it binds to serotonin receptors in the brain, the exact mode of action remains uncertain.
This compound was first created in 1963 by scientists Albert Hofmann and Franz Troxler. Its psychoactivity was not immediately tested. By 1999, David E. Nichols highlighted its potential for pharmacological studies as a cost-effective alternative to psilocybin. Its recreational use started gaining traction in the 2010s following its presence in online research chemical markets.
This synthesized 4-AcO-DMT offers a potential alternative for research purposes, showcasing a comprehensive 4-aco-dmt synthesis process.
Our team brings together the best specialists from different fields.
We are ready to share our experience, discuss difficult issues and find new solutions.